<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Marjan Dzeparoski</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Safety and labelling in non-EU Countries</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacy &amp; Pharmacology International Journal</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2021</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">https://doi.org/10.15406/ppij.2021.09.00322</style></url></web-urls></urls><volume><style face="normal" font="default" size="100%">9</style></volume><pages><style face="normal" font="default" size="100%">27-28</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p&gt;Serialization is driving operational value and is adding safety securing distribution chain against counterfeit and adulterated products. Developing countries are much more vulnerable to this worldwide problem. Readers will learn about regulatory requirements in the countries of interest: Macedonia, Serbia, Montenegro, Bosnia &amp;amp; Herzegovina, Albania and Kosovo. Readers will get in-depth look concerning safety &amp;amp; labelling and will be updated with the country specific environments, as well as with serialization main benefits and the future perspectives.&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">2</style></issue></record></records></xml>